BCL2A1 and chronic myelogenous leukemia, BCR-ABL1 positive: Upregulation of selected genes (BCL2A1, ALOX15 and SMAD7) by imatinib in CML iCD34+ cells was confirmed by qPCR analysis (Supplementary Figure S3c).